These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23169863)

  • 1. Pathogenic long-lived plasma cells and their survival niches in autoimmunity, malignancy, and allergy.
    Winter O; Dame C; Jundt F; Hiepe F
    J Immunol; 2012 Dec; 189(11):5105-11. PubMed ID: 23169863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of long-lived plasma cells in autoimmunity.
    Arce S; Cassese G; Hauser A; Dörner T; Odendahl M; Manz R; Radbruch A; Hiepe F
    Immunobiology; 2002 Dec; 206(5):558-62. PubMed ID: 12607731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow of NZB/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: implications for the treatment of autoimmunity.
    Mumtaz IM; Hoyer BF; Panne D; Moser K; Winter O; Cheng QY; Yoshida T; Burmester GR; Radbruch A; Manz RA; Hiepe F
    J Autoimmun; 2012 Sep; 39(3):180-8. PubMed ID: 22727274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to cope with pathogenic long-lived plasma cells in autoimmune diseases.
    Hoyer BF; Mumtaz IM; Yoshida T; Hiepe F; Radbruch A
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii87-9. PubMed ID: 19022822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergy for a lifetime?
    Luger EO; Wegmann M; Achatz G; Worm M; Renz H; Radbruch A
    Allergol Int; 2010 Mar; 59(1):1-8. PubMed ID: 20186004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD28 expressed on malignant plasma cells induces a prosurvival and immunosuppressive microenvironment.
    Nair JR; Carlson LM; Koorella C; Rozanski CH; Byrne GE; Bergsagel PL; Shaughnessy JP; Boise LH; Chanan-Khan A; Lee KP
    J Immunol; 2011 Aug; 187(3):1243-53. PubMed ID: 21715687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The establishment of the plasma cell survival niche in the bone marrow.
    Chu VT; Berek C
    Immunol Rev; 2013 Jan; 251(1):177-88. PubMed ID: 23278749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tracking plasma cell differentiation and survival.
    Roth K; Oehme L; Zehentmeier S; Zhang Y; Niesner R; Hauser AE
    Cytometry A; 2014 Jan; 85(1):15-24. PubMed ID: 24700574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-lived plasma cells and their contribution to autoimmunity.
    Hoyer BF; Manz RA; Radbruch A; Hiepe F
    Ann N Y Acad Sci; 2005 Jun; 1050():124-33. PubMed ID: 16014527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma cells as an innovative target in autoimmune disease with renal manifestations.
    Hiepe F; Radbruch A
    Nat Rev Nephrol; 2016 Apr; 12(4):232-40. PubMed ID: 26923204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma cells].
    Hiepe F; Alexander T; Voll RE
    Z Rheumatol; 2015 Feb; 74(1):20-5. PubMed ID: 25616773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors implicated in the generation and persistence of long-lived plasma cell-mediated autoimmunity.
    Neves M; Alves JD
    Autoimmun Rev; 2011 May; 10(7):375-82. PubMed ID: 21224017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foxp3+ regulatory T cells control humoral autoimmunity by suppressing the development of long-lived plasma cells.
    Jang E; Cho WS; Cho ML; Park HJ; Oh HJ; Kang SM; Paik DJ; Youn J
    J Immunol; 2011 Feb; 186(3):1546-53. PubMed ID: 21209284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competence and competition: the challenge of becoming a long-lived plasma cell.
    Radbruch A; Muehlinghaus G; Luger EO; Inamine A; Smith KG; Dörner T; Hiepe F
    Nat Rev Immunol; 2006 Oct; 6(10):741-50. PubMed ID: 16977339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term survival of plasma cells.
    Chu VT; Beller A; Nguyen TT; Steinhauser G; Berek C
    Scand J Immunol; 2011 Jun; 73(6):508-11. PubMed ID: 21352257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinations of B cell fate in immunity and autoimmunity.
    Noelle RJ; Erickson LD
    Curr Dir Autoimmun; 2005; 8():1-24. PubMed ID: 15564715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of APRIL - A proliferation inducing ligand - In autoimmune diseases and expectations from its targeting.
    Baert L; Manfroi B; Casez O; Sturm N; Huard B
    J Autoimmun; 2018 Dec; 95():179-190. PubMed ID: 30385081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Static and dynamic components synergize to form a stable survival niche for bone marrow plasma cells.
    Zehentmeier S; Roth K; Cseresnyes Z; Sercan Ö; Horn K; Niesner RA; Chang HD; Radbruch A; Hauser AE
    Eur J Immunol; 2014 Aug; 44(8):2306-17. PubMed ID: 24777940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoantibodies and antibody-secreting cells].
    Hiepe F; Dörner T
    Z Rheumatol; 2005 Sep; 64(6):389-95. PubMed ID: 16184346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel insights into the role of interleukin-27 and interleukin-23 in human malignant and normal plasma cells.
    Giuliani N; Airoldi I
    Clin Cancer Res; 2011 Nov; 17(22):6963-70. PubMed ID: 21880791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.